Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-252,462
Closed -$17.5M 106
2026
Q1
$17.5M Buy
252,462
+91,793
+57% +$7.07M 1.08% 31
2025
Q4
$12.2M Sell
160,669
-67,583
-30% -$5.43M 0.86% 33
2025
Q3
$19.7M Buy
228,252
+37,874
+20% +$2.86M 2.29% 12
2025
Q2
$13M Sell
190,378
-75,328
-28% -$4.66M 1.58% 24
2025
Q1
$15.8M Sell
265,706
-25,824
-9% -$1.64M 2.99% 14
2024
Q4
$17.6M Sell
291,530
-125,839
-30% -$7.7M 2.58% 11
2024
Q3
$30.1M Buy
417,369
+224,366
+116% +$15.7M 4.23% 6
2024
Q2
$13.6M Buy
+193,003
New +$14.8M 1.85% 21

Other funds holding APTV

Covalis Capital's APTV Position: Q2 2026 in Review

Covalis Capital sold out of Aptiv (APTV) in Q2 2026, closing a stake of 252,462 shares — an estimated $17.5M sold.

Covalis Capital first reported a position in APTV in Q2 2024 and held it in 8 quarters. The position peaked at $30.1M in Q3 2024. 659 funds tracked by Wall St. Rank hold APTV as of Q2 2026.

  • Covalis Capital reported no remaining Aptiv position as of Q2 2026 after selling out during the quarter.
  • Covalis Capital sold 252,462 Aptiv shares in Q2 2026, an estimated $17.5M.
  • Covalis Capital first reported a position in Aptiv in Q2 2024 and held it in 8 quarters.
  • Covalis Capital's Aptiv position peaked at $30.1M in Q3 2024.
  • 659 funds tracked by Wall St. Rank held Aptiv as of Q2 2026.

Based on Covalis Capital's 13F filing for Q2 2026, filed 13 Aug 2026.